safety and efficacy of allogenic car-t cell treatment
Published 4 years ago • 40 plays • Length 2:53Download video MP4
Download video MP3
Similar videos
-
1:26
the safety and efficacy of allosct following car-t cell therapy for large b-cell lymphoma
-
8:37
safety and efficacy of cd7-targeted car-t therapy in patients with r/r t-all and t-lbl
-
2:16
evaluating the safety and efficacy of novel anti-cd7 universal car-t therapy in r/r t-all and t-lbl
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
3:14
using machine learning to identify trajectories of hematotoxicity following car t-cell therapy
-
3:43
the future of car-t therapy
-
0:59
identifying molecular markers for the prediction of icaht in patients receiving car t-cell therapy
-
3:33
an overview of the car t-cell therapy story
-
1:02
the use of car-t cell products in a real-world setting
-
2:34
safety considerations in car-t therapy: patient selection and side effects
-
3:47
update on the guidelines for the diagnosis, grading & management of icaht following car-t therapy
-
1:10
tackling resistance to car-t therapy across hematological malignancies
-
2:20
the risk of t-cell malignancies associated with car t-cell therapy
-
2:41
cell avidity as a predictor of t-cell efficacy
-
2:05
the cost-effectiveness of car t-cell therapy
-
1:22
safety and efficacy of cesnicabtagene autoleucel (ari0002h) for r/r mm
-
1:35
key mechanisms of resistance to car t-cell therapy
-
2:38
car-t therapy for aggressive b-cell lymphomas